TY - JOUR
T1 - Bladder dysfunction and management in multiple sclerosis
AU - Andrews, Karen L.
AU - Husmann, Douglas A.
PY - 1997
Y1 - 1997
N2 - Symptomatic bladder dysfunction occurs at some time in most patients with multiple sclerosis. The relapsing-remitting course and progressive loss of mobility associated with multiple sclerosis make management of urinary urgency and incontinence difficult. Urodynamic evaluation serves as a guideline for appropriate treatment. After accurate diagnosis of bladder dysfunction, a management program is developed with use of fluid schedules, voiding techniques, neuropharmacologic manipulation, intermittent catheterization, surgical treatment, and other adjunctive measures as indicated. The goals of treatment are to protect and preserve renal function, relieve symptomatic voiding dysfunction, and avoid subsequent urinary complications. A management program should be individualized, dynamic, and monitored with periodic, systematic urologic review to maintain these goals.
AB - Symptomatic bladder dysfunction occurs at some time in most patients with multiple sclerosis. The relapsing-remitting course and progressive loss of mobility associated with multiple sclerosis make management of urinary urgency and incontinence difficult. Urodynamic evaluation serves as a guideline for appropriate treatment. After accurate diagnosis of bladder dysfunction, a management program is developed with use of fluid schedules, voiding techniques, neuropharmacologic manipulation, intermittent catheterization, surgical treatment, and other adjunctive measures as indicated. The goals of treatment are to protect and preserve renal function, relieve symptomatic voiding dysfunction, and avoid subsequent urinary complications. A management program should be individualized, dynamic, and monitored with periodic, systematic urologic review to maintain these goals.
UR - http://www.scopus.com/inward/record.url?scp=0030668772&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030668772&partnerID=8YFLogxK
U2 - 10.4065/72.12.1176
DO - 10.4065/72.12.1176
M3 - Article
C2 - 9413302
AN - SCOPUS:0030668772
SN - 0025-6196
VL - 72
SP - 1176
EP - 1183
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 12
ER -